PREMPHASE (PREMARIN;CYCRIN 14/14) Drug Patent Profile

✉ Email this page to a colleague

When do Premphase (premarin;cycrin 14/14) patents expire, and what generic alternatives are available?

Premphase (premarin;cycrin 14/14) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in PREMPHASE (PREMARIN;CYCRIN 14/14) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PREMPHASE (PREMARIN;CYCRIN 14/14)?
What are the global sales for PREMPHASE (PREMARIN;CYCRIN 14/14)?
What is Average Wholesale Price for PREMPHASE (PREMARIN;CYCRIN 14/14)?

Summary for PREMPHASE (PREMARIN;CYCRIN 14/14)

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	71
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PREMPHASE (PREMARIN;CYCRIN 14/14)
DailyMed Link:	PREMPHASE (PREMARIN;CYCRIN 14/14) at DailyMed

Drug patent expirations by year for PREMPHASE (PREMARIN;CYCRIN 14/14)

US Patents and Regulatory Information for PREMPHASE (PREMARIN;CYCRIN 14/14)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	PREMPHASE (PREMARIN;CYCRIN 14/14)	estrogens, conjugated; medroxyprogesterone acetate	TABLET;ORAL-28	020303-002	Dec 30, 1994		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PREMPHASE (PREMARIN;CYCRIN 14/14)

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	PREMPHASE (PREMARIN;CYCRIN 14/14)	estrogens, conjugated; medroxyprogesterone acetate	TABLET;ORAL-28	020303-002	Dec 30, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PREMPHASE (PREMARIN;CYCRIN 14/14)

See the table below for patents covering PREMPHASE (PREMARIN;CYCRIN 14/14) around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Hungary	T67553		⤷ Sign Up
Netherlands	980038		⤷ Sign Up
Australia	711571		⤷ Sign Up
Germany	10199010		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for PREMPHASE (PREMARIN;CYCRIN 14/14)

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0136011	97C0056	Belgium	⤷ Sign Up	PRODUCT NAME: OESTROGENES CONJUGUES + MEDROXYPROGESTERONACETAS; NAT. REGISTRATION NO/DATE: 428 IS 194 F 3 19970520; FIRST REGISTRATION: CH 52649 19940826
0136011	2000C/027	Belgium	⤷ Sign Up	PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0136011	SPC/GB00/028	United Kingdom	⤷ Sign Up	SPC/GB00/028: 20040802, EXPIRES: 20090801
0136011	980038	Netherlands	⤷ Sign Up	980038, 20090801, EXPIRES: 20130305
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for PREMPHASE (PREMARIN;CYCRIN 14/14)

Make Better Decisions: Try a trial or see plans & pricing